OGT's first dedicated fusion MRD NGS panel targets the roughly one-quarter of AML cases where RNA fusion transcripts, not DNA ...

Discover how researchers are looking beyond individual neurons to understand how genetic variations shape activity across ...

Explore how dual binding assays reveal interactions between bispecific antibodies and their targets, providing insights into ...

This whitepaper outlines a practical framework for designing scientifically justified, regulatory-ready IND packages that ...

Welcome to the Weekly Rundown where the DDN editors cover this week’s top biotech and pharma news.

BCG vaccination reduced tau pathology and neuroinflammation in mice, prompting researchers to investigate whether trained immunity could inform future treatments for Alzheimer’s disease.

Advances in biolayer interferometry enable the analysis of small molecule interactions, providing new insights into binding kinetics and affinity.